BNTC

Benitec Biopharma Inc.

2.95 USD
-0.78 (-20.91%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Benitec Biopharma Inc. stock is down -3.91% since 30 days ago. The next earnings date is May 13, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 55.56% of the previous 8 February’s closed higher than January. 100% of analysts rate it a buy.

About Benitec Biopharma Inc.

Benitec Biopharma focuses on the development of novel genetic medicines. The company is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. BB-103 for the treatment of chronic hepatitis B virus infection.